Correlation between Frailty and Nutrition, Psychological, and Physical Function in Patients with Decompensated Cirrhosis: A Cross-Sectional Study Based on the Liver Frailty Index
Objective: This study investigates the relationship between frailty (assessed via the Liver Frailty Index), nutrition, negative emotions (depression and anxiety), and physical function in decompensated cirrhosis patients, aiming to provide scientific evidence for clinical treatment strategies. Methods: A cross-sectional study was conducted involving 477 decompensated cirrhosis patients. Data were collected using general information questionnaires, the 2002 Nutrition Risk Screening Scale, the Self-Rating Anxiety Scale, the Self-Rating Depression Scale, the Daily Living Activity Rating Scale, the Morse Fall Risk Assessment Scale, and the Liver Frailty Index. A binary logistic regression model was employed to analyze the associations between frailty and nutritional status, negative emotions, and physical function. Results: The prevalence of frailty in cirrhosis patients was 21.38%. Univariate analysis revealed that patients with frailty showed significantly worse outcomes in age, gender, nutritional indicators (body mass index, potassium ion, prealbumin, albumin, hemoglobin), fall risk, activity capacity, nutritional risk, depression and anxiety scores, as well as complications (ascites, bleeding) compared to those without frailty. The binary logistic regression analysis further identified depression scores (OR = 1.03) and hemoglobin levels (OR = 0.98) as independent factors contributing to increased frailty. Higher depression scores were associated with significantly elevated risks of frailty. The lower the hemoglobin level, the greater the patient’s frailty index. Additionally, aging, elevated Morse fall risk score, and decreased ADL (Activities of Daily Living) scores have been confirmed as independent correlates of frailty. Conclusion: Frailty in decompensated cirrhosis patients is significantly associated with advanced age, depressive mood, nutritional anemia, high fall risk, and reduced baseline mobility. Therefore, clinical interventions should extend beyond conventional liver disease management by integrating psychological support (particularly for depression), targeted nutritional interventions (to correct anemia), fall prevention strategies, and functional rehabilitation exercises. This multidimensional approach aims to delay or reverse frailty progression and improve overall patient outcomes.
References
[1]
Nan, Y.M. (2017) Current Status and Prospects of Diagnosis and Treatment of Complications in Liver Cirrhosis. ChineseJournalofHepatology, 25, 241-245.
[2]
China Society of Integrated Traditional and Western Medicine, Professional Com-mittee of Digestive System Diseases (2025) Expert Consensus on the Diagnosis and Treatment of Cirrhosis Ascites with Integrated Traditional and Western Medicine. JournalofClinicalHepatobiliaryDiseases, 41, 828-838.
[3]
Liu, X., Zhu, D., Guo, Q., et al. (2025) Correlation Analysis and Countermeasures of frailty and Malnutrition Risk Factors in Patients with Decompensated Cirrhosis. NursingResearch, 39, 3474-3478.
[4]
Kusnik, A., Penmetsa, A., Chaudhary, F., Renjith, K., Ramaraju, G., Laryea, M., et al. (2024) Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients with Liver Cirrhosis. GastroenterologyResearch, 17, 53-63. https://doi.org/10.14740/gr1707
[5]
Zhou, Z., He, N., Zhang, S., et al. (2024) Analysis of the Current Status and Influencing Factors of Frailty in Hospitalized Patients with Hepatitis B Cirrhosis. ContemporaryNurse (MidweekEdition), 31, 153-157.
[6]
Nardelli, S., Pentassuglio, I., Pasquale, C., Ridola, L., Moscucci, F., Merli, M., et al. (2013) Depression, Anxiety and Alexithymia Symptoms Are Major Determinants of Health Related Quality of Life (HRQOL) in Cirrhotic Patients. MetabolicBrainDisease, 28, 239-243. https://doi.org/10.1007/s11011-012-9364-0
[7]
Tang, W., Sun, Y., Wang, P., et al. (2023) Application of NRS-2002 in Nutritional Risk Screening for Inpatients with Cardiovascular Diseases and Analysis of Related Factors. ModernMedicine, 51, 758-764.
[8]
Shao, Q., Wu, C., Sun, L., et al. (2024) Application Analysis of Fall Risk Assessment Scale in Neurology Patients. ContemporaryNurse (LateEdition), 31, 65-69.
[9]
Williams, F.R., Milliken, D., Lai, J.C. and Armstrong, M.J. (2021) Assessment of the Frail Patient with End‐Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. HepatologyCommunications, 5, 923-937. https://doi.org/10.1002/hep4.1688
[10]
Elsheikh, M., Sabagh, A.E., Mohamed, I.B., Bhongade, M., Hassan, M.M. and Jalal, P.K. (2023) Frailty in End-Stage Liver Disease: Understanding Pathophysiology, Tools for Assessment, and Strategies for Management. WorldJournalofGastroenterology, 29, 6028-6048. https://doi.org/10.3748/wjg.v29.i46.6028
[11]
Baldemir, R., Öztürk, A., Eraslan Doganay, G., Cirik, M.O. and Alagoz, A. (2022) Evaluation of Nutritional Status in Hospitalized Chronic Obstructive Pulmonary Disease Patients and Can C-Reactive Protein-to-Albumin Ratio Be Used in the Nutritional Risk Assessment in These Patients. Cureus, 14, e21833. https://doi.org/10.7759/cureus.21833
[12]
Xu, C., Shen, Q., Huang, L., et al. (2018) Advances in Nutritional Assessment Methods for Chronic Kidney Disease Patients. NursingResearch, 32, 1354-1356.
[13]
Yan, X., Wang, W. and Zhao, D. (2022) Analysis of Anemia Characteristics in Patients with Alcoholic Cirrhosis. JournalofClinicalHepatobiliaryDiseases, 38, 1806-1812.
[14]
Gkamprela, E. (2017) Iron Deficiency Anemia in Chronic Liver Disease: Etiopathogenesis, Diagnosis and Treatment. AnnalsofGastroenterology, 30, 405-413. https://doi.org/10.20524/aog.2017.0152
[15]
Terbah, R., Testro, A., Gow, P., Majumdar, A. and Sinclair, M. (2023) Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis—Pathogenesis, Implications and Therapeutic Opportunities. Nutrients, 16, Article 35. https://doi.org/10.3390/nu16010035
[16]
Donlan, J., Kaplan, A., Noll, A., Pintro, K., Horick, N., Zeng, C., et al. (2025) Prognostic Communication, Symptom Burden, Psychological Distress, and Quality of Life among Patients with Decompensated Cirrhosis. ClinicalGastroenterologyandHepatology, 23, 1746-1754.e4. https://doi.org/10.1016/j.cgh.2024.10.017
[17]
Albayrak, B., Ozcan, H., Aksungur, N. and Cankaya, E. (2023) Depression and Anxiety Symptoms in Patients with Cirrhosis: A Prospective Study before and after Liver Transplantation. TransplantationProceedings, 55, 1644-1648. https://doi.org/10.1016/j.transproceed.2023.04.040
[18]
Yang, P., Wang, J., Ning, H., et al. (2024) A Study on the Effect of a Liver Disease Diet APP in Improving Malnutrition and frailty in Patients with Cirrhosis. JournalofGastroenterologyandHepatology, 33, 265-271.
[19]
Shen, S., Jin, Y., Gao, F., et al. (2024) Advances in the Impact of Frailty on Adverse Health Outcomes in Patients with Liver Cirrhosis. Evidence-BasedNursing, 10, 433-437.
[20]
Wang, C. and Yan, J. (2022) Current Research Status and Intervention Methods for Chronic Hepatitis B Patients with Depression. NursingResearch, 36, 437-441.
[21]
Li, A., Yang, M., Liu, Y., et al. (2025) The Impact of Empathetic Nursing on Anxiety and Depression in Patients with Liver Cirrhosis. JournalofRareDiseases, 32, 170-172.
[22]
Sun, R. (2025) Correlation Study on Portal Vein Thrombosis in Patients with Sarcopenia and Liver Cirrhosis. Xi’an Medical University.
[23]
Dajti, E., Renzulli, M., Ravaioli, F., Marasco, G., Vara, G., Brandi, N., et al. (2023) The Interplay between Sarcopenia and Portal Hypertension Predicts Ascites and Mortality in Cirrhosis. DigestiveandLiverDisease, 55, 637-643. https://doi.org/10.1016/j.dld.2022.11.011
[24]
Tapper, E.B., Risech-Neyman, Y. and Sengupta, N. (2015) Psychoactive Medications Increase the Risk of Falls and Fall-Related Injuries in Hospitalized Patients with Cirrhosis. ClinicalGastroenterologyandHepatology, 13, 1670-1675. https://doi.org/10.1016/j.cgh.2015.03.019
[25]
Tapper, E.B., Nikirk, S., Parikh, N.D. and Zhao, L. (2021) Falls Are Common, Morbid, and Predictable in Patients with Cirrhosis. JournalofHepatology, 75, 582-588. https://doi.org/10.1016/j.jhep.2021.04.012
[26]
Fulop, T., Larbi, A., Witkowski, J.M., McElhaney, J., Loeb, M., Mitnitski, A., et al. (2010) Aging, Frailty and Age-Related Diseases. Biogerontology, 11, 547-563. https://doi.org/10.1007/s10522-010-9287-2
[27]
Ferrucci, L. and Fabbri, E. (2018) Inflammageing: Chronic Inflammation in Ageing, Cardiovascular Disease, and Frailty. NatureReviewsCardiology, 15, 505-522. https://doi.org/10.1038/s41569-018-0064-2
[28]
Vilas, J.M., Carneiro, C., Da Silva‐Álvarez, S., Ferreirós, A., González, P., Gómez, M., et al. (2018) Adult Sox2+ Stem Cell Exhaustion in Mice Results in Cellular Senescence and Premature Aging. AgingCell, 17, e12834. https://doi.org/10.1111/acel.12834